NasdaqGM:ADMABiotechs
ADMA Biologics (ADMA) Valuation After Revenue Growth Guidance Reaffirmation And CFO Transition
ADMA Biologics (ADMA) shares are in focus after the company paired strong 2025 revenue and earnings with reaffirmed multi year guidance, yield focused operational changes, and a CFO transition aimed at supporting execution.
See our latest analysis for ADMA Biologics.
At a share price of US$15.57, ADMA has seen a 1 day share price return of 2.57%. However, the 30 day and year to date share price returns of 8.47% and 12.92% declines suggest recent momentum has cooled. This follows a very large...